GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid

Analyse Crystal structure of human ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6MD4
Type
protein
Length
509 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
BRL, OLA
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25867% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25167% helix, 5% strandP37231

Ligands and binding sites

  • BRL · 2,4-thiazolidiinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-(9CL) · ligand · chains A
  • OLA · Oleic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17290.810.8472empty
24750.790.8650BRL, OLA
33130.580.7725empty
4950.530.8420empty
51710.450.7521empty

Interfaces

1 interface between chains.

  • A–B · 1005 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 6MD4 · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.